LivaNova PLC (LIVN)

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Address

20 EASTBOURNE TERRACE
LONDON, X0 W2 6LG

Founded

2015

Number of Employees

2,900

Website

http://www.livanova.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - $5,120 $54,377 - $49,991 - - - - - - $36,496
Average Price - $69.95 $49.89 - $99.91 - - - - - - $65.82
# Shares Purchased - 73,193 1,089,874 - 500,333 - - - - - - 554,467
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - -31.4% -3.8% - -52.0% - - - - - - -27.1%
S&P 500 Return to Date - 173.0% 168.6% - 104.9% - - - - - - 148.8%
Excess Total Return - -204.3% -172.4% - -156.8% - - - - - - -175.9%
Quartile Rank
Percentile Rank - 22% 30% - 12% - - - - - - 25%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
Axonics, Inc.
Surgery Partners, Inc.
KOZY WILLIAM A

LivaNova PLC
AtriCure, Inc.